Literature DB >> 31476643

Route of administration effects on nicotine discrimination in female and male mice.

Timothy W Lefever1, Brian F Thomas1, Alexander L Kovach1, Rodney W Snyder1, Jenny L Wiley2.   

Abstract

BACKGROUND: Use of electronic cigarettes (e-cigarettes) has increased exponentially since their appearance on the U.S. market around 2007. To provide preclinical models of vaping that incorporate olfactory cues and chemosensory effects (including flavors) that play a role in human vaping behavior, the feasibility of using a modified e-cigarette device for delivery of aerosolized nicotine was examined in a nicotine discrimination procedure in mice.
METHODS: Adult female and male C57BL/6 mice were trained to discriminate 0.75 mg/kg subcutaneous (s.c.) nicotine from saline. After determination of a s.c. nicotine dose-effect curve, aerosolized freebase nicotine and nicotine-containing tobacco products (i.e., non-flavored and Arctic Blast e-liquids) were evaluated.
RESULTS: Nicotine (s.c.) dose-dependently substituted in mice of both sexes, although females showed less sensitivity and greater variability. By contrast, aerosolized nicotine, regardless of formulation, produced concentration-dependent increases up to maximum of 46-62% nicotine-associated responding. Brain nicotine concentrations for each sex were similar for s.c. 0.75 mg/kg nicotine and 30 mg/ml freebase nicotine.
CONCLUSIONS: Mice of both sexes readily acquired s.c. nicotine discrimination, but females showed less sensitivity. Further, all three formulations of aerosolized nicotine produced increases in nicotine-like responding in mice of each sex. However, the maximum magnitude of these increases did not engender a similar degree of substitution as s.c. 0.75 mg/kg nicotine, despite similar brain concentrations of nicotine at 30 mg/ml aerosolized nicotine. Additional research is needed for determination of the reason(s); however, results here demonstrate initial feasibility for examination of the discriminative stimulus effects of vaped drugs such as nicotine.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Discrimination; Nicotine; Route of administration; Sex differences

Year:  2019        PMID: 31476643      PMCID: PMC6878166          DOI: 10.1016/j.drugalcdep.2019.06.007

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  47 in total

Review 1.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

Review 2.  Flavour preferences in youth versus adults: a review.

Authors:  Allison C Hoffman; Raydel Valdes Salgado; Carolyn Dresler; Rachel Williams Faller; Christopher Bartlett
Journal:  Tob Control       Date:  2016-09-15       Impact factor: 7.552

3.  Exposure to chronic intermittent nicotine vapor induces nicotine dependence.

Authors:  Olivier George; Taryn E Grieder; Maury Cole; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2010-04-24       Impact factor: 3.533

4.  Nicotine as a discriminative stimulus: a neurobehavioral approach to studying central cholinergic mechanisms.

Authors:  J A Rosecrans
Journal:  J Subst Abuse       Date:  1989

5.  Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: Application of a novel methodology.

Authors:  Nicholas I Goldenson; Matthew G Kirkpatrick; Jessica L Barrington-Trimis; Raina D Pang; Julia F McBeth; Mary Ann Pentz; Jonathan M Samet; Adam M Leventhal
Journal:  Drug Alcohol Depend       Date:  2016-09-22       Impact factor: 4.492

6.  Characterization of an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration.

Authors:  Keith L Shelton; Galina Slavova-Hernandez
Journal:  Pharmacol Biochem Behav       Date:  2009-03-04       Impact factor: 3.533

Review 7.  Sex differences in nicotine intravenous self-administration: A meta-analytic review.

Authors:  Rodolfo J Flores; Kevin P Uribe; Natashia Swalve; Laura E O'Dell
Journal:  Physiol Behav       Date:  2017-11-21

8.  Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice.

Authors:  Timothy W Lefever; Julie A Marusich; Brian F Thomas; Daniel G Barrus; Nicholas C Peiper; Richard C Kevin; Jenny L Wiley
Journal:  Subst Abuse       Date:  2017-04-07

Review 9.  Electronic cigarettes: product characterisation and design considerations.

Authors:  Christopher J Brown; James M Cheng
Journal:  Tob Control       Date:  2014-05       Impact factor: 7.552

Review 10.  E-cigarettes: a scientific review.

Authors:  Rachel Grana; Neal Benowitz; Stanton A Glantz
Journal:  Circulation       Date:  2014-05-13       Impact factor: 29.690

View more
  4 in total

Review 1.  Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.

Authors:  Asti Jackson; Ben Grobman; Suchitra Krishnan-Sarin
Journal:  Neuropharmacology       Date:  2020-06-24       Impact factor: 5.250

Review 2.  History repeats itself: Role of characterizing flavors on nicotine use and abuse.

Authors:  Theresa Patten; Mariella De Biasi
Journal:  Neuropharmacology       Date:  2020-06-01       Impact factor: 5.250

3.  The Role of Nicotine and Flavor in the Abuse Potential and Appeal of Electronic Cigarettes for Adult Current and Former Cigarette and Electronic Cigarette Users: A Systematic Review.

Authors:  Mari S Gades; Aleksandra Alcheva; Amy L Riegelman; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2022-08-06       Impact factor: 5.825

4.  Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer.

Authors:  Meng Wang; Yue Li; Yunyun Xiao; Muwen Yang; Jinxin Chen; Yunting Jian; Xin Chen; Dongni Shi; Xiangfu Chen; Ying Ouyang; Lingzhi Kong; Xinjian Huang; Jiewen Bai; Chuyong Lin; Libing Song
Journal:  Nat Commun       Date:  2021-12-01       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.